Zhan Hao, Song Ying, Stephanie Wu, Lv Hongjie

China’s competition watchdog SAMR made a penalty decision, adopted by its Shanghai branch Shanghai Market Regulation Bureau (“SMRB”), publicized on its official website[1] on April 29, 2019, right before the International Labor Day holiday. This decision is addressed to Eastman (China) Investment Management Co., Ltd. (“Eastman

He Jing/Jerry Xia

On March 18, 2019, China announced amendments of its joint venture law and the Regulations on Administration of Technology Import and Export (TIER) with immediate effect. The changes in nature took away some of the restrictions around cross border technology transfers, delivering more freedom of contract for future transactions. The announcement has

Bo Hu, Partner

On March 15, 2019, China’s national legislature, the National People’s Congress passed the Foreign Investment Law (the “Law”), a landmark legislation that will provide stronger protection and a better business environment for foreign investors. The Law will take effective on January 1,2020.

Upon its effectiveness, the Law will replace China’s current foreign

Bo Hu

On March 15, 2019, China’s national legislature, the National People’s Congress passed the Foreign Investment Law (the “Law”), a landmark legislation that will provide stronger protection and a better business environment for foreign investors. The Law will take effective on January 1, 2020. Upon its effectiveness, the Law will replace China’s current foreign

He Jing, Jerry Xia

February 3 was the deadline for the Standing Committee of the National People’s Congress of China to accept the public comments on the new version of the proposed Draft Amendments to the Patent Law (“the Draft”).  This new draft is the result of the first reading at the end of December

Zhan Hao, Song Ying, Yang Zhan

The year 2018 should be a milestone for Anti-Monopoly Law of the People’s Republic of China (“AML”) enforcement and development in China.

On May 9, 2018, the newly established State Administration for Market Regulation (“SAMR”), as a sole Chinese antitrust and competition authority, has

Authored by Zhan Hao (zhanhao@anjielaw.com) and Sharif Hendry (sharifhendry@anjielaw.com) at AnJie Law Firm

As of today, the recently adopted ‘China Risk Oriented Solvency System’, also known as “C-ROSS”, is the only regime by which a Mainland insurer’s capital adequacy is regulated. Following the implementation of China’s 13th Five-Year plan in 2016, the China Insurance Regulatory